← Back to Search

Ekso Users for Spinal Cord Injury

N/A
Waitlist Available
Research Sponsored by Ekso Bionics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion for a maximum possible duration of 42 months
Awards & highlights

Study Summary

The purpose of the study is to study the safety and health effects of using the Ekso Bionics powered exoskeleton device in a home setting over an extended period, ranging from 12-42 months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion for a maximum possible duration of 42 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion for a maximum possible duration of 42 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Study Participants With Adverse Events
Secondary outcome measures
Borg Perceived Rate of Exertion
International Spinal Cord Injury Data Sets
International Spinal Cord Injury Data Sets Bladder Function Basic Data Set - Number of Participants Who Reported Changes in Bladder Function
+7 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Ekso UsersExperimental Treatment1 Intervention
SCI subjects using Ekso
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ekso
2014
N/A
~70

Find a Location

Who is running the clinical trial?

Ekso BionicsLead Sponsor
3 Previous Clinical Trials
125 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Investigational Study of the Ekso for High-Dosage Use by Individuals With SCI in a Non-Clinical Environment
2014. "Investigational Study of the Ekso for High-Dosage Use by Individuals With SCI in a Non-Clinical Environment". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02566850.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top